(UPDATED) Ischemia with no obstructive coronary arteries (INOCA) produces symptoms that affect physical functioning, mental health, and quality of life, a new survey of patients diagnosed with the ...
Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...
CHICAGO -- The WARRIOR trial was not able to prove that intensive medical therapy reduced major adverse cardiovascular events (MACE) in women with ischemia but no obstructive disease. For symptomatic ...
BETHESDA, Md., March 30, 2026--(BUSINESS WIRE)--CorVista Health, a leader in noninvasive cardiovascular diagnostics, today announced new data evaluating a physiologic signal–based machine-learning ...
Ischemia with No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction with No Obstructive Coronary Arteries (MINOCA) are two underdiagnosed, potentially fatal forms of heart disease that ...
A new study led by investigators at the Smidt Heart Institute at Cedars-Sinai found symptoms of the increasingly common cardiovascular condition known as ischemia with no obstructive coronary arteries ...
CHICAGO -- Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring new frontiers for GLP-1 drugs in cardiovascular medicine, and foundational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results